Site updated at Wednesday, 22 June 2016

Living with Dementia


Sanofi to test Parkinson’s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson’s disease.

Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi’s AVE8112, a drug that has shown promise… Sanofi to test Parkinson’s drug with Michael J. Fox Foundation   

Alzheimer’s Disease

non-familial parkinson's1 - tfp5 treatment1 - difficulties with swallowing1 - cognitive abilities1 - apraxia3 - depression14 - play-up programme1 - sporadic parkinson's disease1 - abeta1 - novel proteins1 - omega-3s1 - impaired balance and coordination1 - frontotemporal dementia symptoms1 - risk of stroke1 - pocd1 - risk of alzheimer's3 - parkinson disease3 - rem-sleep behavior disorder1 - psychometrics1 - obesity2 - huntingtons disease4 - dementia sufferers1 - movement tremors1 - solanezumab1 - tavi2 - psychiatric status rating scales1 - mayo clinic1 - initiative1 - thiamine deficiency4 - α-synuclein protein2 -